Here, our study showed that borneol can improve TMZ chemotherapy sensitivity, and that HIF-1α is a potential target for improving the antitumor efficacy of TMZ, which is closely related to the promotion of the autophagic degradation of HIF-1α, thus improving chemotherapy sensitivity in glioma cells. This evidence concerns the gene HIF1A and central nervous system cancer.